Quotes 5-day view Real-time Euronext Amsterdam
02/22/2021
02/23/2021
02/24/2021
02/25/2021
02/26/2021
Date
141.1(c)
139.9(c)
138(c)
138.7(c)
136.55 Last
362 216
413 866
362 111
304 320
535 857 Volume
-0.91% -0.85% -1.36% +0.51% -1.55% Change
Sales 2020
8 439 M 10 223 M 10 223 M
Net income 2020
654 M 793 M 793 M
Net Debt 2020
2 831 M 3 430 M 3 430 M
P/E ratio 2020
37,5x
Yield 2020
1,80%
Sales 2021
8 715 M 10 559 M 10 559 M
Net income 2021
918 M 1 112 M 1 112 M
Net Debt 2021
1 046 M 1 267 M 1 267 M
P/E ratio 2021
24,7x
Yield 2021
1,85%
Capitalization
23 520 M 28 753 M 28 494 M
EV / Sales 2020
3,12x
EV / Sales 2021
2,82x
Nbr of Employees
23 127
Free-Float
94,7%
Royal DSM specializes in the development, manufacture and marketing of performance materials, and nutritional and pharmaceutical ingredients. The products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics. Net sales (not including sold divisions) by...
All news about ROYAL DSM N.V.
News in other languages on ROYAL DSM N.V.
Analyst Recommendations on ROYAL DSM N.V.
What is the science behind the moo-ve from cattle methane emissions?
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ROYAL DSM N.V.
Short Term Mid-Term Long Term Trends Bearish Neutral Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
25
Average target price
150,37 €
Last Close Price
138,70 €
Spread / Highest target
29,8%
Spread / Average Target
8,42%
Spread / Lowest Target
-43,8%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
